Authors:
de Haas, TGKJ
Zwaan, CM
Wondergem, MJ
Pieters, R
Kaspers, GJL
Loonen, AH
Rottier, MMA
Wunsche, R
Creutzig, U
Bartl, S
Hahlen, K
Broxterman, HJ
Ossenkoppele, GJ
Veerman, AJP
Citation: Tgkj. De Haas et al., In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children, HEMAT BLOOD, 40, 2001, pp. 244-250
Authors:
Zwaan, CM
Kaspers, GJL
Pieters, R
Ramakers-Van Woerden, NL
den Boer, ML
Wunsche, R
Rottier, MMA
Hahlen, K
van Wering, ER
Janka-Schaub, GE
Creutzig, U
Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2779-2786
Authors:
Zwaan, CM
Kaspers, GJL
Pieters, R
Woerden, NLR
den Boer, ML
Wunsche, R
Rottier, MMA
Hahlen, K
van Wering, ER
Janka-Schaub, GE
Creutzig, U
Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2879-2886
Authors:
Kaspers, CJL
Zwaan, CM
Veerman, AJP
Rots, MG
Pieters, R
Bucsky, P
Domula, M
Gobel, U
Graf, N
Havers, W
Jorch, N
Kabisch, K
Spaar, HJ
Ritter, J
Creutzig, U
Citation: Cjl. Kaspers et al., Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study, KLIN PADIAT, 211(4), 1999, pp. 239-244